First Trust Advisors LP Athenex, Inc. Transaction History

First Trust Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.36 - $2.94 $151,301 - $327,077	-111,251 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $330,415 - $538,454	111,251 New	111,251 $335,000
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $469,004 - $1.7 Million	-114,952 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$11.06 - $14.01 $175,289 - $222,044	15,849 Added 15.99%	114,952 $1.27 Million
Q3 2020 Nov 05, 2020	BUY	$10.26 - $14.55 $1.02 Million - $1.44 Million	99,103 New	99,103 $1.2 Million
Q2 2019 Jul 30, 2019	SELL	$9.44 - $19.8 $811,840 - $1.7 Million	-86,000 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$11.11 - $13.49 $955,460 - $1.16 Million	86,000 New	86,000 $1.05 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.